An Overview About Erythrocyte Membrane
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
STA-601-Sphingomyelin-Assay-Kit.Pdf
Introduction Phospholipids are important structural lipids that are the major component of cell membranes and lipid bilayers. Phospholipids contain a hydrophilic head and a hydrophobic tail which give the molecules their unique characteristics. Most phospholipids contain one diglyceride, a phosphate group, and one choline group. Sphingomyelin (ceramide phosphorylcholine) is a sphingolipid found in eukaryotic cell membranes and lipoproteins. Sphingomyelin usually consists of a ceramide and phosphorylcholine molecule where the ceramide core comprises of a fatty acid bonded via an amide bond to a sphingosine molecule. There is a polar head group which is either phosphphoethanolamine or phosphocholine. Sphingomyelin represents about 85% of all sphingolipids and makes up about 10-20% of lipids within the plasma membrane. Sphingomyelin is involved in signal transduction and is highly concentrated in the myelin sheath around many nerve cell axons. The plasma membranes of many cells are rich with sphingomyelin. Sphigolipids are synthesized in a pathway that originates in the ER and is completed in the Golgi apparatus. Many of their functions are done in the plasma membranes and endosomes. Sphingomyelin is converted to ceramide via sphingomyelinases. Ceramides have been implicated in signaling pathways that lead to apoptosis, differentiation and proliferation. Sphingomyelins have been implicated in the pathogenesis of atherosclerosis, inflammation, necrosis, autophagy, senescence, stress response as well as other signaling disease states. Niemann-Pick disease is an inherited disease where deficiency of sphingomyelinase activity results in sphingomyelin accumulating in cells, tissues, and fluids. Other sphingolipid diseases are Fabry disease, Gaucher disease, Tay-Sachs disease, Krabbe disease and Metachromatic leukodystrophy. Cell Biolabs’ Sphingomyelin Assay Kit is a simple fluorometric assay that measures the amount of sphingomyelin present in plasma or serum, tissue homogenates, or cell suspensions in a 96-well microtiter plate format. -
Gene List HTG Edgeseq Immuno-Oncology Assay
Gene List HTG EdgeSeq Immuno-Oncology Assay Adhesion ADGRE5 CLEC4A CLEC7A IBSP ICAM4 ITGA5 ITGB1 L1CAM MBL2 SELE ALCAM CLEC4C DST ICAM1 ITGA1 ITGA6 ITGB2 LGALS1 MUC1 SVIL CDH1 CLEC5A EPCAM ICAM2 ITGA2 ITGAL ITGB3 LGALS3 NCAM1 THBS1 CDH5 CLEC6A FN1 ICAM3 ITGA4 ITGAM ITGB4 LGALS9 PVR THY1 Apoptosis APAF1 BCL2 BID CARD11 CASP10 CASP8 FADD NOD1 SSX1 TP53 TRAF3 BCL10 BCL2L1 BIRC5 CASP1 CASP3 DDX58 NLRP3 NOD2 TIMP1 TRAF2 TRAF6 B-Cell Function BLNK BTLA CD22 CD79A FAS FCER2 IKBKG PAX5 SLAMF1 SLAMF7 SPN BTK CD19 CD24 EBF4 FASLG IKBKB MS4A1 RAG1 SLAMF6 SPI1 Cell Cycle ABL1 ATF1 ATM BATF CCND1 CDK1 CDKN1B NCL RELA SSX1 TBX21 TP53 ABL2 ATF2 AXL BAX CCND3 CDKN1A EGR1 REL RELB TBK1 TIMP1 TTK Cell Signaling ADORA2A DUSP4 HES1 IGF2R LYN MAPK1 MUC1 NOTCH1 RIPK2 SMAD3 STAT5B AKT3 DUSP6 HES5 IKZF1 MAF MAPK11 MYC PIK3CD RNF4 SOCS1 STAT6 BCL6 ELK1 HEY1 IKZF2 MAP2K1 MAPK14 NFATC1 PIK3CG RORC SOCS3 SYK CEBPB EP300 HEY2 IKZF3 MAP2K2 MAPK3 NFATC3 POU2F2 RUNX1 SPINK5 TAL1 CIITA ETS1 HEYL JAK1 MAP2K4 MAPK8 NFATC4 PRKCD RUNX3 STAT1 TCF7 CREB1 FLT3 HMGB1 JAK2 MAP2K7 MAPKAPK2 NFKB1 PRKCE S100B STAT2 TYK2 CREB5 FOS HRAS JAK3 MAP3K1 MEF2C NFKB2 PTEN SEMA4D STAT3 CREBBP GATA3 IGF1R KIT MAP3K5 MTDH NFKBIA PYCARD SMAD2 STAT4 Chemokine CCL1 CCL16 CCL20 CCL25 CCL4 CCR2 CCR7 CX3CL1 CXCL12 CXCL3 CXCR1 CXCR6 CCL11 CCL17 CCL21 CCL26 CCL5 CCR3 CCR9 CX3CR1 CXCL13 CXCL5 CXCR2 MST1R CCL13 CCL18 CCL22 CCL27 CCL7 CCR4 CCRL2 CXCL1 CXCL14 CXCL6 CXCR3 PPBP CCL14 CCL19 CCL23 CCL28 CCL8 CCR5 CKLF CXCL10 CXCL16 CXCL8 CXCR4 XCL2 CCL15 CCL2 CCL24 CCL3 CCR1 CCR6 CMKLR1 CXCL11 CXCL2 CXCL9 CXCR5 -
Cholesterol-Sphingomyelin Interactions in Cells-Effects on Lipid Metabolism
Chapter 10 Cholesterol-Sphingomyelin Interactions in Cells-Effects on Lipid Metabolism J. Peter Slotte 1. INTRODUCTION Both cholesterol and sphingomyelin are important constituents of cellular plasma membranes. The molecules are chemically and functionally very different, yet they appear to be attracted to each other in the membrane compartment. It is the aim of this review to discuss how alterations in their membrane interactions may affect lipid homeostasis in cells, and to suggest a molecular explanation for their mutual affinity in membranes. Recent reviews dealing with the subcellular distribution and transport of cholesterol (Liscum and Dahl, 1992; Liscum and Faust, 1994; Liscum and Under wood, 1995), with cellular lipid traffic (van Meer, 1989; Pagano, 1990; Voelker, 1991; Allan and Kallen, 1993), with transport and metabolism of sphingomyelin (Koval and Pagano, 1991), and with the role of sphingolipids in cell signaling (Kolesnick, 1991, 1994; Hannun and Bell, 1993; Hannun, 1994), may also be of interest to the reader. 2. CELLULAR DISTRIBUTION OF CHOLESTEROL 2.1. Cell Cholesterol Homeostasis Cholesterol is an essential component of cellular plasma membranes in higher organisms. Cholesterol interacts with membrane phospholipids and J. Peter SloUe Department of Biochemistry and Pharmacy, Abo Akademi University, FIN 20520 Turku, Finland. Subcellular Biochemistry, Volume 28: Cholesterol: Its Functions and Metabolism in Biology and Medi cine, edited by Robert Bittman. Plenum Press, New York. 1997. R. Bittman (ed.), Cholesterol 277 © Plenum Press, New York 1997 278 J. Peter Slotte influences their physico-chemical properties. The important membrane proper ties that are directly or indirectly influenced by membrane levels of cholesterol include solute permeability (for a review, see Yeagle, 1985), phospholipid acyl chain mobility (GaIly et ai., 1976; Stockton and Smith, 1976, Yeagle, 1985) and lateral packing (Chapman et ai., 1969; Lund-Katz et ai., 1988; Smaby et ai., 1994). -
Phospholipid Composition of the Mammalian Red Cell Membrane Can Be Rationalized by a Superlattice Model
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 4964–4969, April 1998 Biophysics Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model J. A. VIRTANEN*†,K.H.CHENG‡, AND P. SOMERHARJU§¶ *Department of Chemistry, University of California, Irvine, CA 92697; ‡Department of Physics, Texas Tech University, Lubbock, TX 79409-1051; and §Institute of Biomedicine, Department of Medical Chemistry, University of Helsinki, 00014 Helsinki, Finland Communicated by John A. Glomset, University of Washington, Seattle, WA, February 10, 1998 (received for review October 31, 1996) ABSTRACT Although the phospholipid composition of present head group SL model is similar to the earlier model but the erythrocyte membrane has been studied extensively, it makes two specific assumptions. First, phospholipid head groups remains an enigma as to how the observed composition arises represent the basic lattice elements. Second, phospholipid species and is maintained. We show here that the phospholipid with an identical or similar (in terms of size andyor charge) polar composition of the human erythrocyte membrane as a whole, head group are considered equivalent, i.e., they form a single as well as the composition of its individual leaflets, is closely equivalency class. Accordingly, the choline phospholipids (CPs), predicted by a model proposing that phospholipid head phosphatidylcholine (PC) and sphingomyelin (SM), form one groups tend to adopt regular, superlattice-like lateral distri- class; the acidic phospholipids (APs), phosphatidylserine (PS), butions. The phospholipid composition of the erythrocyte phosphatidylinositol (PI), and phosphatidic acid (PA), form membrane from most other mammalian species, as well as of another; and phosphatidylethanolamine (PE) alone forms the the platelet plasma membrane, also agrees closely with the third class. -
Rabbit Anti-Phospho-CD18-SL10462R-FITC
SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-Phospho-CD18 SL10462R-FITC Product Name: Anti-Phospho-CD18 (Thr758)/FITC Chinese Name: FITC标记的磷酸化整合素β2/Integrin β2抗体 CD18 (Phospho Thr758); CD18 (Phospho-Thr758); CD18 (Phospho T758); p-CD18 (T758); p-CD18 (Thr758); Integrin beta 2; 95 subunit beta; CD 18; CD18; Cell surface adhesion glycoprotein LFA 1/CR3/P150,959 beta subunit precursor); Cell surface adhesion glycoproteins LFA 1/CR3/p150,95 subunit beta; Cell surface adhesion glycoproteins LFA-1/CR3/p150; Complement receptor C3 beta subunit; Complement Alias: receptor C3 subunit beta; Integrin beta chain beta 2; Integrin beta-2; Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit); ITB2_HUMAN; ITGB2; LAD; LCAMB; Leukocyte associated antigens CD18/11A, CD18/11B, CD18/11C; Leukocyte cell adhesion molecule CD18; LFA 1; LFA1; Lymphocyte function associated antigen 1; MAC 1; MAC1; MF17; MFI7; OTTHUMP00000115278; OTTHUMP00000115279; OTTHUMP00000115280; OTTHUMP00000115281; OTTHUMP00000115282. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep,Guinea Pig, Flow-Cyt=1:50-200ICC=1:50-200IF=1:50-200www.sunlongbiotech.com Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 82kDa Form: Lyophilized or Liquid Concentration: 1mg/ml KLH conjugated synthesised phosphopeptide derived from human CD18 around the immunogen: phosphorylation site of Thr758 Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. -
Anti-ICAM4 Monoclonal Antibody (DCABH-11966) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
Anti-ICAM4 monoclonal antibody (DCABH-11966) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description This gene encodes the Landsteiner-Wiener (LW) blood group antigen(s) that belongs to the immunoglobulin (Ig) superfamily, and that shares similarity with the intercellular adhesion molecule (ICAM) protein family. This ICAM protein contains 2 Ig-like C2-type domains and binds to the leukocyte adhesion LFA-1 protein. The molecular basis of the LW(A)/LW(B) blood group antigens is a single aa variation at position 100; Gln-100=LW(A) and Arg-100=LW(B). Alternative splicing results in multiple transcript variants encoding distinct isoforms. Immunogen A synthetic peptide of human ICAM4 is used for rabbit immunization. Isotype IgG Source/Host Rabbit Species Reactivity Human Purification Protein A Conjugate Unconjugated Applications Western Blot (Transfected lysate); ELISA Size 1 ea Buffer In 1x PBS, pH 7.4 Preservative None Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. GENE INFORMATION Gene Name ICAM4 intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) [ Homo sapiens ] Official Symbol ICAM4 Synonyms ICAM4; intercellular adhesion molecule 4 (Landsteiner-Wiener blood group); intercellular adhesion molecule 4 (LW blood group) , intercellular adhesion molecule 4, Landsteiner Wiener blood group , Landsteiner Wiener blood group , LW; intercellular adhesion molecule 4; CD242; CD242 antigen; LW blood group protein; Landsteiner-Wiener blood group -
Genetic Testing Policy Number: PG0041 ADVANTAGE | ELITE | HMO Last Review: 04/11/2021
Genetic Testing Policy Number: PG0041 ADVANTAGE | ELITE | HMO Last Review: 04/11/2021 INDIVIDUAL MARKETPLACE | PROMEDICA MEDICARE PLAN | PPO GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder terms, conditions, exclusions and limitations contract. It does not constitute a contract or guarantee regarding coverage or reimbursement/payment. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This medical policy is solely for guiding medical necessity and explaining correct procedure reporting used to assist in making coverage decisions and administering benefits. SCOPE X Professional X Facility DESCRIPTION A genetic test is the analysis of human DNA, RNA, chromosomes, proteins, or certain metabolites in order to detect alterations related to a heritable or acquired disorder. This can be accomplished by directly examining the DNA or RNA that makes up a gene (direct testing), looking at markers co-inherited with a disease-causing gene (linkage testing), assaying certain metabolites (biochemical testing), or examining the chromosomes (cytogenetic testing). Clinical genetic tests are those in which specimens are examined and results reported to the provider or patient for the purpose of diagnosis, prevention or treatment in the care of individual patients. Genetic testing is performed for a variety of intended uses: Diagnostic testing (to diagnose disease) Predictive -
Analysis of Serum Sphingomyelin Species by Uflc-Ms/Ms in Patients
aphy & S r ep og a t r a a t m i o o r n Lazzarini et al., J Chromatogr Sep Tech 2014, 5:5 h T e C c f Journal of Chromatography h DOI: 10.4172/2157-7064.1000239 o n l i a q ISSN:n 2157-7064 u r e u s o J Separation Techniques Research Article OpenOpen Access Access Analysis of Serum Sphingomyelin Species by Uflc-Ms/Ms in Patients Affected with Monoclonal Gammopathy Lazzarini A1, Floridi A1, Pugliese L1, Villani M1, Cataldi S1, Michela Codini2, Lazzarini R1, Beccari T2, Ambesi-Impiombato FS3, Curcio F3 and Albi E1* 1Laboratory of Nuclear Lipid BioPathology, CRABiON, Perugia, Italy 2Department of Pharmaceutical Science, University of Perugia, Italy 3Department of Clinical and Biological Sciences, University of Udine, Italy Abstract Cancer cells are hungry of cholesterol incorporated from serum with avidity and used to favour the expressions of proteins involved in cell proliferation such as RNA polymerase II, STAT3, PKCz and cyclin D1. Numerous studies have shown that exists a strong interaction between unesterified cholesterol and saturated fatty acid sphingomyelin which arises from the Van der Waals interaction. Since sphingomyelin and cholesterol association is responsible for the formation of membrane lipid raft involved in cell signalling, we studied the possible hyposphingomyelinemia associated to hypocholesterolemia in the patients with cancer. The blood of 23 patients with monoclonal gammopathy were analyzed for cholesterol, 12:0 sphingomyelin, 16:0 sphingomyelin and 18:1sphingomyelin content. The results demonstrated that only the patients with very low level of cholesterol (65-99 mg/dl) had low amount of sphingomyelin and, in particular, of saturated sphingomyelin specie (16:0 sphingomyelin). -
Red Blood Cell Antigen Genotyping
Red Blood Cell Antigen Genotyping Testing is useful in determining allelic variants predicting red blood cell (RBC) antigen phenotypes for patients with recent history of transfusion or with conflicting serological antibody results due to partial, variant, or weak expression antigens. Also Tests to Consider useful as an aid in management of hemolytic disease of the fetus and newborn (HDFN). Typical Testing Strategy Disease Overview Phenotype Testing Evaluates specific RBC antigen presence by serology Prevalence and/or Incidence Results can aid in selecting antigen negative RBC units Erythrocyte alloimmunization occurs in up to 58% of sickle cell patients, up to 35% in other transfusion-dependent patients, and in approximately 0.8% of all pregnant Antigen Testing, RBC Phenotype women. Extended 0013020 Method: Hemagglutination Serological testing includes K, Fya, Fyb, Jka, Symptoms Jkb, S, s (k, cellano, testing performed if indicated) to assess maternal or paternal RBC Transfusion reactions or HDFN can occur due to alloimmunization: phenotype status. Antigen Testing, Rh Phenotype 0013019 Intravascular hemolysis: hemoglobinuria, jaundice, shock Extravascular hemolysis: fever and chills Method: Hemagglutination HDFN: fetal hemolytic anemia, hepatosplenomegaly, jaundice, erythroblastosis, Antigen testing for D, C, E, c, and e to assess neurological damage, hydrops fetalis maternal, paternal, or newborn Rh phenotype status Clinical presentation is variable and dependent upon the specific antibody and recipient factors Genotype Testing May help -
Mirepoix LLC on Behalf of Caris Life Sciences, June 22, 2020 No Revisions to These Recommendations
0211U Oncology (pan-tumor), DNA and RNA by next generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. Public Comment Rationale • Recommendation to crosswalk 0211U MI Cancer Seek is a combined whole transcriptome AND whole exome to 0019U (NLA=$3675.00) + 0036U sequencing test that is equivalent to (NLA=$4780.00) performing both: • 0019U: Oncology, RNA, gene expression • 1x multiplier for each by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue • Recommendation of an NLA equal to or fresh frozen tissue, predictive $8455 for 0211U algorithm reported as potential targets for therapeutic agents • 0036U: Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. 0019U* 0211U 0036U** Assay type Whole Whole Whole Whole Transcriptome Transcriptome Exome Exome Sequencing Sequencing Sequencing Sequencing Platform NGS NGS (Illumina) NGS (Illumina) RNASeq RNASeq & DNASeq DNASeq Samples tested FFPE & frozen tumor tissue FFPE tumor tissue FFPE tumor tissue -
Neuronal Ceroid Lipofuscinosis Related ER Membrane Protein CLN8 Regulates PP2A Activity and Ceramide Levels T
BBA - Molecular Basis of Disease 1865 (2019) 322–328 Contents lists available at ScienceDirect BBA - Molecular Basis of Disease journal homepage: www.elsevier.com/locate/bbadis Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels T Babita Adhikaria,1, Bhagya De Silvab,c,1,2, Joshua A. Molinaa, Ashton Allena, Sun H. Pecka,3, ⁎ Stella Y. Leea,b, a Division of Biology, Kansas State University, Manhattan, KS 66506, USA b Graduate Biochemistry Group, Kansas State University, Manhattan, Kansas 66506, USA c Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas 66506, USA ARTICLE INFO ABSTRACT Keywords: The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative lysosomal storage dis- CLN8 orders. CLN8 deficiency causes a subtype of NCL, referred to as CLN8 disease. CLN8 is an ER resident protein PP2A with unknown function; however, a role in ceramide metabolism has been suggested. In this report, we identified I2PP2A PP2A and its biological inhibitor I2PP2A as interacting proteins of CLN8. PP2A is one of the major serine/ Ceramide threonine phosphatases in cells and governs a wide range of signaling pathways by dephosphorylating critical Neuronal ceroid lipofuscinosis signaling molecules. We showed that the phosphorylation levels of several substrates of PP2A, namely Akt, S6 kinase, and GSK3β, were decreased in CLN8 disease patient fibroblasts. This reduction can be reversed by in- hibiting PP2A phosphatase activity with cantharidin , suggesting a higher PP2A activity in CLN8-deficient cells. Since ceramides are known to bind and influence the activity of PP2A and I2PP2A, we further examined whether ceramide levels in the CLN8-deficient cells were changed. -
Sphingomyelin of Red Blood Cells in Lipidosis and in Dementia of Unknown Origin in Children
Arch Dis Child: first published as 10.1136/adc.44.234.197 on 1 April 1969. Downloaded from Arch. Dis. Childh., 1969, 44, 197. Sphingomyelin of Red Blood Cells in Lipidosis and in Dementia of Unknown Origin in Children G. J. M. HOOGHWINKEL, H. H. VAN GELDEREN, and A. STAAL From the Laboratory of Medical Chemistry and the Departments of Paediatrics and Neurology, University of Leiden, The Netherlands Histological and chemical examinations of biopsy no diagnosis could be made, are briefly described in specimens from cerebral tissue of children suffering Table I. Incomplete investigation made it impossible to from undiagnosed progressive brain disease are reach a diagnosis in Cases 7 and 8. The molar con- performed increasingly. Important information centrations of phospholipids in the red blood cells therapeutic have been determined as described by Hooghwinkel is provided, which, though rarely of and Niekerk (1960), Hooghwinkel and Borri (1964), value, does increase precision of diagnosis, and Hooghwinkel, Borri, and Bruyn (1966). The prognosis, and genetic advice (Cumings, 1965a, amounts of the various phospholipids of red blood b, c; Poser, 1962; Adams, 1965). This is especially cells have been expressed as molar percentages of true of the chemical investigations, and it is likely total phospholipids. Absolute values of phospho- that chernical analyses will challenge the current lipids depend a good deal on size and shape of the classifications of progressive brain disease. Amaur- otic idiocy has already proved to be more hetero- 36 copyright. 0 geneous than was thought hitherto, while supposedly -a .A a different diseases, such as Niemann-Pick's and 0 34 .